Insiders Brainstorm Cell Therapeutics Inc.

Equities

BCLI

US10501E2019

Market Closed - Nasdaq Other stock markets 01:30:00 27/06/2024 am IST			5-day change	1st Jan Change
0.3912 ^USD	-0.18%		-2.22%	+43.30%

26/06	Brainstorm Cell Therapeutics Inc. Reaches Alignment with Fda on Cmc Aspects of Phase 3B Nurown®? Clinical Trial	CI
20/06	Brainstorm Cell Therapeutics Announces Appointment of Haro Hartounian as EVP and COO	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Brainstorm Cell Therapeutics Announces Appointment of Haro Hartounian as EVP and COO	20/06	CI
Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024	17/04	CI
Brainstorm Cell Therapeutics Inc. Announces Management Changes	17/04	CI
Brainstorm Cell Therapeutics Inc. Announces Executive Changes	21/12	CI
Brainstorm Cell Therapeutics Inc. Announces Resignation of Dr. Kirk Taylor as EVP and Chief Medical Officer	24/23/24	CI
BrainStorm Cell Therapeutics Inc. Appoints Bob Dagher as Executive Vice President and Chief Development Officer	12/23/12	CI
Brainstorm Cell Therapeutics Appoints Nir Naor as Board Member and Audit Committee Chair	21/23/21	CI
Brainstorm Cell Therapeutics Chief Operating Officer David Setboun Resigns	25/23/25	MT
Brainstorm Cell Therapeutics Inc Announces Resignation of David Setboun as Executive Vice President and Chief Operating Officer	25/23/25	CI
Brainstorm Cell Therapeutics Inc. Announces Appointment of Kirk Taylor as Executive Vice President and Chief Medical Officer, Effective May 1, 2023	25/23/25	CI
BrainStorm Cell Therapeutics Announces Promotion of Dr. Stacy Lindborg to Co-Chief Executive Officer	04/23/04	CI
Brainstorm Cell Therapeutics Inc. Appoints Antal Pearl-Lendner as Chief Legal Counsel	12/22/12	CI
Brainstorm Cell Therapeutics Inc. Announces Retirement of Sankesh Abbhi as Board of Director	18/21/18	CI
Brainstorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs	08/21/08	CI
Brainstorm Cell Therapeutics Inc. Announces Board Changes	28/21/28	CI
Cidara Therapeutics : Appoints Preetam Shah Chief Financial Officer	01/21/01	MT
Brainstorm Cell Therapeutics Inc. Announces Executive Changes	26/21/26	CI
Brainstorm Cell Therapeutics Inc. Appoints William K. White as Senior Vice President, Head of Market Access & Pricing	29/20/29	CI
Brainstorm Cell Therapeutics Inc. Appoints Anthony Waclawski as Executive Vice President, Global Head of Regulatory Affairs	02/20/02	CI
Brainstorm Appoints Stacy R. Lindborg, as Executive Vice President, Head of Global Clinical Research	27/20/27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Brainstorm Cell Therapeutics Inc.

Equities

BCLI

US10501E2019

Insiders

Filters